Yuval Cohen - 13 Feb 2022 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Chief Executive Officer, Director
Signature
/s/Yuval Cohen
Issuer symbol
CRBP
Transactions as of
13 Feb 2022
Net transactions value
$0
Form type
4
Filing time
15 Feb 2023, 11:44:21 UTC
Previous filing
02 Feb 2022
Next filing
09 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option (right to buy) Award $0 +1,989,546 $0.000000 1,949,546 13 Feb 2023 Common Stock 1,989,546 $0.1420 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024.